The company launched in 2023 with $90 million in funding from organizations including Johnson & Johnson’s venture capital arm.
The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...
Accurate detection of PIK3CA mutations is essential for personalizing breast cancer treatment, particularly with PI3K-targeted therapies. However, conventional molecular testing is not always ...
QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...
Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use its artificial-intelligence-powered lung cancer diagnostic as part of an ...
Scientists at the Stowers Institute for Medical Research, Helmholtz Munich, the Technical University of Munich, and the University of Oxford have developed RegVelo - a new AI framework that ...
Researchers unveiled two major AI advances: a brain-inspired training method that improves confidence accuracy in predictions ...
By Brittany Cordeiro Mayo Clinic and Stanford Medicine researchers have developed the first blood test to map the complex ...
As technology advances, so does scientific progress. Artificial intelligence (AI) methods have rapidly progressed beyond data classification and prediction. These new capabilities make the use of AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results